Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Centene: 1.4+ million sign up for 2018 Obamacare

U.S. health insurer Centene Corp. said more than 1.4 million people had paid for its insurance plans via the federal Obamacare marketplace as of Jan. 7, 2018.

Read More »

2017 Annual Report: State Of The Bio Industry

R&D success and M&A activity loom as large swing factors for the bio sector in 2017 with the regulatory arena potentially at its most amenable for years.

Read More »

Price controls threaten industry profits and promotional spend

Whatever comes out of Congress on the “repeal and replace” of the Affordable Care Act (ACA or Obamacare) matters because it will affect the bottom line of the life sciences industry as well as all of its industry partners.

Read More »

House panels to launch fight in Congress over Obamacare replacement

A potentially lengthy U.S. legislative fight over replacement of the Obamacare health law got underway as two House of Representatives committees begin negotiating over changes to a Republican plan backed by President Donald Trump.

Read More »

Trump, Republicans set timeframe for introducing Obamacare replacement

President Donald Trump and Republicans in Congress said they will unveil plans to repeal and replace Obamacare, providing a timeframe for a legislative goal they have struggled with for weeks.

Read More »

Benchmark 2017 premiums up 25%

The average premium for benchmark 2017 Obamacare insurance plans sold on rose 25 percent compared with 2016, the U.S. government said, the biggest increase since the insurance first went on sale in 2013 for the following year.

Read More »

House Speaker Ryan unveils Republican alternative to Obamacare

U.S. Speaker of the House Paul Ryan (R-WI) takes questions at a news conference in Washington, U.S. May 12, 2016. Reuters/Jim Bourg/Files U.S. House of Representatives Speaker Paul Ryan unveiled a Republican healthcare agenda on Wednesday that would repeal Obamacare but keep some of its more popular provisions. The proposal is part of Ryan’s blueprint, […]

Read More »

Special Feature — Agenda 2016: Bigger, better, faster, more

Or, why 2016 might look a little different than 2015 for pharmaceutical marketers.

Read More »

Ex-FDA Head Accused of Conspiring to Suppress Information About Harmful Effects of Johnson & Johnson Antibiotic

WASHINGTON — Margaret Hamburg, the former commissioner of the U.S. Food and Drug Administration, conspired to conceal harmful side effects of Johnson & Johnson (JNJ)’s antibiotic drug Levaquin, according to a lawsuit filed by six patients, Qmed reported this morning. The lawsuit alleges that Hamburg suppressed information about the drug’s side effects so her husband, […]

Read More »

Healthcare Agency Roundtable 2015

Executives from the 2015 and 2014 Manny Award winners and finalists share their views on a variety of industry-related topics.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom